This result is not displayed to guests.
Login for full access.

Strength Dependence of Cadherin-Mediated Adhesions

Authors: Ladoux, Benoit, Anon, Ester, Lambert, Mireille, Rabodzey, Aleksandr, Hersen, Pascal, Buguin, Axel, Silberzan, Pascal, Mège, René-Marc

Source: In Biophysical Journal 2010 98(4):534-542

Mechanical Forces Induced by the Transendothelial Migration of Human Neutrophils

Authors: Rabodzey, Aleksandr, Alcaide, Pilar, Luscinskas, Francis W., Ladoux, Benoit

Source: In Biophysical Journal 2008 95(3):1428-1438

Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress.

Authors: Yao, Yu, Rabodzey, Aleksandr, Dewey, C. Forbes Jr

Source: American Journal of Physiology; August 2007 pt2, Vol. 293 Issue 2, pH1023-H1030, 8p

Endothelial actin cytoskeleton remodeling during mechanostimulation with fluid shear stress.

Authors: Osborn, Eric A., Rabodzey, Aleksandr, Dewey, C. Forbes Jr

Source: American Journal of Physiology; February 2006 pt1, Vol. 290 Issue 2, pC444-C452, 9p

Early Response of Endothelial Cells to Flow Is Mediated by VE-Cadherin.

Authors: Rabodzey, Aleksandr¹ (AUTHOR), Yao, Yu¹ (AUTHOR), Luscinskas, Francis W.² (AUTHOR), Shaw, Sunil K.³ (AUTHOR), Dewey, C. Forbes¹ (AUTHOR)

Source: Cell Communication & Adhesion. Nov2007, Vol. 14 Issue 5, p195-209. 15p. 1 Color Photograph, 2 Diagrams, 8 Graphs.

Subject Terms: *CELLS, *CADHERINS, *CELL adhesion molecules, *ACTIN, *MOLECULES, *CYTOSKELETON

Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress.

Authors: Yu Yao, Rabodzey, Aleksandr, Dewey Jr., C. Forbes

Source: American Journal of Physiology: Heart & Circulatory Physiology; Aug2007, Vol. 293 Issue 2, pH1023-H1030, 8p, 5 Graphs

Subject Terms: VASCULAR endothelium, CELLS, LAMINAR flow, ATHEROSCLEROSIS, CELL proliferation

This result is not displayed to guests.
Login for full access.

The state of bioweapons.

Authors: Guillemin, Jeanne, Nasatir, David, Dobbins, Allan, Rabodzey, Aleksandr, Hessel, Andrew, Popov, Serguei, Macfarlane, Allison

Source: Technology Review (Cambridge, Mass.). May-June, 2006, Vol. 109 Issue 2, p8, 1 p.

Multiple Myeloma: Patients, Penetration Price and Duration Offer Upside for Celgene Through 2015.

Authors: Porges, Geoffrey C. geoffrey.porges@bernstein.com, Rahmani, Amrita amrita.rahmani@bernstein.com, Rabodzey, Aleksandr a.rabodzey@bernstein.com

Source: Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015. Apr2011, preceding p1-146. 144p. 1 Illustration, 8 Diagrams, 86 Charts, 79 Graphs.

Subject Terms: *Market potential, *Economic demand, *Business forecasting, Multiple myeloma treatment, Drug marketing, Therapeutics

Geographic Terms: United States

Gilead: New HIV Combos and Pipeline Catalysts Should Drive Earnings and Stock Upside.

Authors: Porges, Geoffrey C. geoffrey.porges@bernstein.com, Rahmani, Amrita amrita.rahmani@bernstein.com, Rabodzey, Aleksandr a.rabodzey@bernstein.com

Source: Bernstein Black Book - The Best of Bernstein: U.S. Edition (Fourth-Quarter 2011). Oct2011, p123-128. 6p.

Subject Terms: *Drug prices, *Corporate finance, *Corporate growth, *Valuation of corporations, Therapeutics, HIV infections, Pharmaceutical research, Drug development

Company/Entity: Gilead Sciences Inc. 185049848 GILD

Celgene: Near-Term Catalysts Likely to Restore Confidence, Lift Outlook.

Authors: Porges, Geoffrey C. geoffrey.porges@bernstein.com, Rahmani, Amrita amrita.rahmani@bernstein.com, Rabodzey, Aleksandr a.rabodzey@bernstein.com

Source: Bernstein Black Book - The Best of Bernstein: Global Edition (Second-Quarter 2011). Oct2011, p213-218. 6p. 2 Charts, 5 Graphs.

Subject Terms: *Sales forecasting, *Business forecasting, Multiple myeloma

Geographic Terms: United States

Company/Entity: Celgene Corp. 174201137 CELG

Portfolio Manager's Summary.

Authors: Porges, Geoffrey C. geoffrey.porges@bernstein.com, Rahmani, Amrita amrita.rahmani@bernstein.com, Rabodzey, Aleksandr a.rabodzey@bernstein.com

Source: Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015. Apr2011, p1-1. 1p.

Subject Terms: *Business forecasting, *Market potential, Multiple myeloma treatment, Drug marketing

Geographic Terms: United States

Company/Entity: Celgene Corp. 174201137 CELG